• Latest Earnings
  • Equities
    Stock Analysis
    Stock Movers
    Deals
    Gainers And Losers
  • IPOs
  • Technology
    Artificial Intelligence
  • Web Stories
  • Benzinga Inspire

    FDA

    6 months ago
    Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug LaunchThis is a major relief for the pharmaceutical industry company as it paves the way for an earlier-than-expected approval and launch of cancer drug gAbraxane.
    1 year ago
    Why This Pharma Giant's Shares Are Down Under Regulatory Pressure
    1 year ago
    Why This Pharma Firm's Shares Are Sinking After US FDA Notice
    6 months ago
    Cipla Skyrockets Over 8% After Dodging Major U.S. Regulatory Hurdle, Paving Way For Much-Awaited Drug Launch
    1 year ago
    Why This Pharma Giant's Shares Are Down Under Regulatory Pressure
    1 year ago
    Why This Pharma Firm's Shares Are Sinking After US FDA Notice
    Loading...
    • Terms & Conditions
    • Do Not Sell My Personal Data/Privacy Policy
    • Disclaimer
    © 2025 Benzinga | All Rights Reserved